GLORIA E GALDAMEZ
Allopathic & Osteopathic Physicians|Family Medicine FREDERICKSBURG, VA NPI 1659565356
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine VA Novo Nordisk AS All categories
General Payments — all program years on this page
$507.43
- Category: General Payments
- Program years: PY2021–2024
- Record count: 25
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $184.13 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $184.13 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $93.01 | 4 |
| BOSTON SCIENTIFIC CORPORATION | $25.24 | 1 |
| Lilly USA, LLC | $23.37 | 1 |
| DEXCOM, INC. | $23.31 | 1 |
| Edwards Lifesciences Corporation | $19.20 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1092343260 | Boston Scientific Corporation | $25.24 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097077723 | Novo Nordisk Inc | $24.37 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097768831 | Novo Nordisk Inc | $24.77 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097810194 | Novo Nordisk Inc | $20.73 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097835425 | Novo Nordisk Inc | $23.14 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1134988294 | Lilly USA, LLC | $23.37 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1138829786 | Edwards Lifesciences Corporation | $19.20 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153301955 | Dexcom, Inc. | $23.31 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.